Skip to content
World of Video Gaming – Lifestyle
Author:
Bluejay Diagnostics, Inc.
Bluejay Achieves Toray Contractual Manufacturing Milestone, Advancing Supply-Chain Resilience and Commercialization Readiness
October 13, 2026
Bluejay Diagnostics Announces SYMON-II Clinical Dataset Details Supporting Evaluation of Mortality Risk in Sepsis and Septic Shock
October 6, 2026
Bluejay Diagnostics & Lovell Partner for Federal Healthcare Market
September 8, 2026
Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony™ IL-6 Toward Regulatory Submission and Commercialization
August 13, 2026
Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study
July 21, 2026
Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules
June 5, 2026
Bluejay Diagnostics Announces up to $23.6 Million Private Placement Priced At-the-Market Under Nasdaq Rules
June 2, 2026
Bluejay Diagnostics and Argonaut Manufacturing Services Announce Strategic Partnership
June 2, 2026
Bluejay Diagnostics Provides First Quarter 2026 Corporate Update
May 7, 2026